Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
san francisco blog main
boston blog main
boston top stories
national top stories
acute myeloid leukemia
adverum biotechnologies
ambit biosciences
athena countouriotis
biobucks
black diamond therapeutics
bladder cancer
blueprint medicines
brett zbar
bristol-myers squibb
calistoga pharmaceuticals
cancer
cancer drugs
car-t immunotherapy
checkpoint inhibitors
clinical trials
cormorant asset management
daiichi sankyo
deciphera pharmaceuticals
eli lilly
endometral cancer
europe blog main
european society for medical oncology
fda
gilead sciences
glioblastoma
halozyme therapeutics
hbm healthcare investments
hbm partners
idelalisib
immuno-oncology
jean cui
kite pharma
What
cancer
3
×
drug
3
×
therapeutics
3
×
biotech
million
new
adding
athena
bets
black
boost
ceo
chief
clinic
companies
countouriotis
diamond
eluded
expensive
far
financing
gets
gilead
hopes
ipo
lead
leading
lines
medical
medicines
mezzanine
molecular
names
nears
officer
old
paying
phase
pipeline
program
Language
unset
Current search:
drug
×
therapeutics
×
cancer
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push